The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels

Inclusion Criteria: * subjects who have atopy but no allergy-related symptoms * subjects with total IgE levels of 300IU/ml or more * acquisition of written informed consent prior to commencement of study * no serious clinical symptoms and normal laboratory test results; in case of abnormal finding, subjects whose conditions are not deemed severe from the judgement of investigators Exclusion Criteria: * individuals with normal levels of total serum IgE * ue of one or more allergic drugs * serious clinical conditions (such as malignancies, severe cardiovascular disease etc.) * serious mental disorder * pregnant woman or woman of childbearing potential within 3 months * subjects who participated in other clinical trials in the past 6months * individuals who have a plan to participate in another clinical trials during this trial * subjects with a history of kiwi allergy * subjects whose conditions are inappropriate by investigators